CD38 and plasma cell myeloma: After obtaining and characterising the EVs as we previously described,4, 30, 31 we synthesised the fluorescein 5‐isothiocyanate (FITC)‐labelled anti‐CD38 peptide (CD38pep, ARGDYYGSNSLDYW)27 and confirmed their binding to the CD38high myeloma cells.